Novocure
NVCR
#4733
Rank
$1.31 B
Marketcap
Jersey
Country
$12.23
Share price
-0.89%
Change (1 day)
-79.94%
Change (1 year)
Categories
Novocure (NVCR) - Cash on Hand
Cash on Hand as of December 2023 : $0.91 B
According to Novocure
's latest financial reports the company has $0.91 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Novocure - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.91 B | -6.07% |
| 2022-12-31 | $0.96 B | 3.38% |
| 2021-12-31 | $0.93 B | 11.29% |
| 2020-12-31 | $0.84 B | 158.39% |
| 2019-12-31 | $0.32 B | 32.62% |
| 2018-12-31 | $0.24 B | 34.13% |
| 2017-12-31 | $0.18 B | -16.54% |
| 2016-12-31 | $0.21 B | -18.48% |
| 2015-12-31 | $0.26 B | 162.57% |
| 2014-12-31 | $0.10 B | -41.66% |
| 2013-12-31 | $0.17 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $5.29 M | -99.42% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | -86.23% | 🇬🇧 UK |
 Novavax NVAX | $0.56 B | -37.57% | 🇺🇸 USA |
 Novocure
NVCR | $0.91 B | 0.00% | Jersey |